bpc-157 human evidence safety clinical trials ๐๐ปโโ๏ธ Is the lack of data in a red flag? โข If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury bpc-157 human clinical trials evidence
Description
Early multiorgan failure, thrombosis, intracranial (superior sagittal sinus) hypertension, portal and caval hypertension, and aortal hypotension, in its full presentation (i.e., giant T-wave) or attenuated by BPC 157 therapy (i.e., normal T-wave) may be decisive for further isoprenaline-lesion development, similar to that noted with major intoxication (i.e., alcohol, lithium) or major vessel occlusion [14,15,16,17,18,19,20,21,22,23]
Although both have benefits, the right option often depends on patient preferences, symptoms, and absorption rates
We included consecutive patients with late window stroke due to M2 occlusion, baseline NIHSS score 5 and premorbid mRS score 2 who received EVT or MM alone
Really keen to hear some perspectives
10.1089/met.2014.0134 37 GoldbergR
Puzzles present an opportunity to gather a family together
